Biomerica Enterprise Value vs Working Capital Analysis

BMRA Stock

USD 0.59 0.03 5.36%

Biomerica financial indicator trend analysis is way more than just evaluating Biomerica prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomerica is a good investment. Please check the relationship between Biomerica Enterprise Value and its Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

Enterprise Value vs Working Capital

Enterprise Value vs Working Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomerica Enterprise Value account and Working Capital. At this time, the significance of the direction appears to have no relationship.

The correlation between Biomerica's Enterprise Value and Working Capital is 0.0. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Working Capital in the same time period over historical financial statements of Biomerica, assuming nothing else is changed. The correlation between historical values of Biomerica's Enterprise Value and Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of Biomerica are associated (or correlated) with its Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Working Capital has no effect on the direction of Enterprise Value i.e., Biomerica's Enterprise Value and Working Capital go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Enterprise Value

Enterprise Value (or EV) is usually referred to as Biomerica theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Biomerica debt, but would also pocket its cash. Enterprise Value is more accurate representation of Biomerica value than its market capitalization because it takes into account all of Biomerica existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Most indicators from Biomerica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.The current year's Tax Provision is expected to grow to about 48 K, whereas Selling General Administrative is forecasted to decline to about 6.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	3.0M	446K	401.4K	381.3K
Total Revenue	18.9M	5.3M	6.1M	7.6M

Gross Profit Total Revenue

Biomerica fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Long Term Debt Total	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.66	0.74	0.99	0.89	-0.88	-0.78	0.94	0.67	0.23	0.94	0.01	0.8	0.77	0.48	0.4	0.89	0.79	0.89	1.0	0.24	-0.33	0.05	-0.11	0.61	0.85
Other Current Liab	0.66		0.74	0.62	0.42	-0.85	-0.63	0.83	0.11	-0.04	0.83	-0.62	0.53	0.39	-0.14	-0.17	0.7	0.58	0.74	0.7	-0.08	-0.17	0.56	0.37	0.22	0.61
Total Current Liabilities	0.74	0.74		0.68	0.69	-0.76	-0.8	0.75	0.47	0.3	0.75	-0.21	0.65	0.8	0.36	0.1	0.74	0.93	0.81	0.75	0.42	-0.15	0.19	-0.03	0.7	0.68
Total Stockholder Equity	0.99	0.62	0.68		0.87	-0.87	-0.75	0.94	0.66	0.18	0.94	0.03	0.78	0.72	0.46	0.44	0.87	0.74	0.86	0.99	0.19	-0.34	0.03	-0.12	0.57	0.83
Property Plant And Equipment Net	0.89	0.42	0.69	0.87		-0.64	-0.73	0.72	0.88	0.5	0.72	0.26	0.72	0.85	0.72	0.37	0.76	0.85	0.81	0.85	0.29	-0.33	-0.12	-0.25	0.72	0.71
Net Debt	-0.88	-0.85	-0.76	-0.87	-0.64		0.65	-0.97	-0.35	0.0	-0.97	0.36	-0.59	-0.55	-0.06	-0.31	-0.76	-0.71	-0.79	-0.91	-0.08	0.15	-0.38	-0.2	-0.38	-0.69
Retained Earnings	-0.78	-0.63	-0.8	-0.75	-0.73	0.65		-0.74	-0.56	-0.14	-0.74	0.12	-0.95	-0.67	-0.6	0.04	-0.95	-0.74	-0.93	-0.78	-0.16	0.52	0.23	0.44	-0.81	-0.94
Cash	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74		0.43	0.05	1.0	-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Non Current Assets Total	0.67	0.11	0.47	0.66	0.88	-0.35	-0.56	0.43		0.47	0.43	0.44	0.54	0.69	0.79	0.32	0.53	0.7	0.59	0.59	0.17	-0.25	-0.33	-0.35	0.72	0.5
Non Currrent Assets Other	0.23	-0.04	0.3	0.18	0.5	0.0	-0.14	0.05	0.47		0.05	0.42	0.1	0.63	0.55	0.18	0.08	0.52	0.06	0.19	0.39	0.16	0.05	-0.02	0.39	0.06
Cash And Short Term Investments	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74	1.0	0.43	0.05		-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Net Receivables	0.01	-0.62	-0.21	0.03	0.26	0.36	0.12	-0.28	0.44	0.42	-0.28		-0.04	0.34	0.57	0.46	-0.14	0.02	-0.2	-0.06	0.43	-0.08	-0.52	-0.4	0.17	-0.09
Common Stock Shares Outstanding	0.8	0.53	0.65	0.78	0.72	-0.59	-0.95	0.73	0.54	0.1	0.73	-0.04		0.63	0.64	0.0	0.97	0.6	0.91	0.79	0.16	-0.58	-0.32	-0.51	0.74	0.99
Non Current Liabilities Total	0.77	0.39	0.8	0.72	0.85	-0.55	-0.67	0.62	0.69	0.63	0.62	0.34	0.63		0.67	0.36	0.66	0.89	0.67	0.75	0.63	-0.13	-0.02	-0.19	0.72	0.62
Inventory	0.48	-0.14	0.36	0.46	0.72	-0.06	-0.6	0.2	0.79	0.55	0.2	0.57	0.64	0.67		0.23	0.52	0.53	0.47	0.42	0.39	-0.39	-0.65	-0.72	0.8	0.56
Other Current Assets	0.4	-0.17	0.1	0.44	0.37	-0.31	0.04	0.28	0.32	0.18	0.28	0.46	0.0	0.36	0.23		0.06	0.28	0.05	0.4	0.44	-0.01	-0.13	-0.13	0.14	0.05
Other Stockholder Equity	0.89	0.7	0.74	0.87	0.76	-0.76	-0.95	0.87	0.53	0.08	0.87	-0.14	0.97	0.66	0.52	0.06		0.68	0.96	0.89	0.14	-0.52	-0.12	-0.32	0.69	0.99
Total Liab	0.79	0.58	0.93	0.74	0.85	-0.71	-0.74	0.71	0.7	0.52	0.71	0.02	0.6	0.89	0.53	0.28	0.68		0.76	0.78	0.43	-0.11	0.1	-0.08	0.77	0.61
Property Plant And Equipment Gross	0.89	0.74	0.81	0.86	0.81	-0.79	-0.93	0.87	0.59	0.06	0.87	-0.2	0.91	0.67	0.47	0.05	0.96	0.76		0.89	0.13	-0.49	-0.04	-0.24	0.67	0.92
Total Current Assets	1.0	0.7	0.75	0.99	0.85	-0.91	-0.78	0.97	0.59	0.19	0.97	-0.06	0.79	0.75	0.42	0.4	0.89	0.78	0.89		0.24	-0.32	0.1	-0.07	0.58	0.85
Accounts Payable	0.24	-0.08	0.42	0.19	0.29	-0.08	-0.16	0.11	0.17	0.39	0.11	0.43	0.16	0.63	0.39	0.44	0.14	0.43	0.13	0.24		0.22	-0.04	-0.18	0.29	0.15
Short Long Term Debt Total	-0.33	-0.17	-0.15	-0.34	-0.33	0.15	0.52	-0.27	-0.25	0.16	-0.27	-0.08	-0.58	-0.13	-0.39	-0.01	-0.52	-0.11	-0.49	-0.32	0.22		0.54	0.55	-0.32	-0.55
Short Term Debt	0.05	0.56	0.19	0.03	-0.12	-0.38	0.23	0.27	-0.33	0.05	0.27	-0.52	-0.32	-0.02	-0.65	-0.13	-0.12	0.1	-0.04	0.1	-0.04	0.54		0.95	-0.45	-0.22
Intangible Assets	-0.11	0.37	-0.03	-0.12	-0.25	-0.2	0.44	0.09	-0.35	-0.02	0.09	-0.4	-0.51	-0.19	-0.72	-0.13	-0.32	-0.08	-0.24	-0.07	-0.18	0.55	0.95		-0.6	-0.42
Common Stock Total Equity	0.61	0.22	0.7	0.57	0.72	-0.38	-0.81	0.45	0.72	0.39	0.45	0.17	0.74	0.72	0.8	0.14	0.69	0.77	0.67	0.58	0.29	-0.32	-0.45	-0.6		0.7
Common Stock	0.85	0.61	0.68	0.83	0.71	-0.69	-0.94	0.81	0.5	0.06	0.81	-0.09	0.99	0.62	0.56	0.05	0.99	0.61	0.92	0.85	0.15	-0.55	-0.22	-0.42	0.7

Click cells to compare fundamentals

Biomerica Account Relationship Matchups

Biomerica fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Other Current Liab	278.6K	540.7K	883.3K	1.2M	1.1M	1.2M
Total Current Liabilities	1.5M	1.3M	2.0M	1.9M	1.8M	1.3M
Total Stockholder Equity	14.2M	9.2M	8.3M	11.7M	13.5M	14.2M
Property Plant And Equipment Net	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Debt	(6.9M)	(2.6M)	(4.5M)	(8.6M)	(7.8M)	(7.4M)
Retained Earnings	(21.9M)	(28.4M)	(35.1M)	(42.2M)	(38.0M)	(36.1M)
Cash	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Non Current Assets Total	2.5M	2.6M	1.9M	1.7M	1.9M	1.3M
Non Currrent Assets Other	168.2K	264.2K	95.6K	79K	71.1K	67.5K
Cash And Short Term Investments	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Net Receivables	1.8M	1.5M	773.8K	722K	649.8K	955.2K
Common Stock Shares Outstanding	10.2M	11.9M	12.7M	14.2M	16.3M	17.1M
Liabilities And Stockholders Equity	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Non Current Liabilities Total	1.6M	1.3M	1.0M	785K	902.8K	857.6K
Inventory	2.9M	3.2M	2.4M	2.1M	2.4M	2.2M
Other Current Assets	1.5M	255.0	447.0	300K	270K	273.8K
Other Stockholder Equity	35.2M	36.7M	42.4M	52.7M	60.6M	63.6M
Total Liab	3.0M	2.6M	3.0M	2.7M	2.5M	1.4M
Property Plant And Equipment Gross	2.0M	1.9M	3.5M	3.2M	3.7M	3.9M
Total Current Assets	14.8M	9.2M	9.4M	12.8M	14.7M	15.5M
Accumulated Other Comprehensive Income	(39.8K)	(48.0K)	(73.9K)	(110K)	(126.5K)	(132.8K)
Accounts Payable	986.7K	431.6K	736K	344K	309.6K	575.0K
Intangible Assets	168.7K	294.8K	170K	165K	148.5K	276.5K
Common Stock Total Equity	711.0K	774.2K	939.2K	984.6K	1.1M	622.7K
Common Stock	939.2K	984.6K	1.0M	1.3M	1.5M	1.6M
Other Assets	168.2K	264.2K	363.0	79K	90.9K	86.3K
Property Plant Equipment	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Tangible Assets	14.0M	8.9M	8.2M	11.6M	13.3M	7.8M
Net Invested Capital	14.2M	9.2M	8.3M	11.7M	13.5M	8.8M
Net Working Capital	13.3M	7.9M	7.4M	10.9M	12.5M	7.9M
Capital Stock	964.9K	984.6K	1.0M	1.3M	1.5M	1.1M

Pair Trading with Biomerica

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biomerica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomerica will appreciate offsetting losses from the drop in the long position's value.

Moving together with Biomerica Stock

0.68

ENSG

Ensign Group

Pair Corr

Moving against Biomerica Stock

0.91	INSP	Inspire Medical Systems	Pair Corr
0.79	GKOS	Glaukos Corp	Pair Corr
0.69	EHC	Encompass Health Corp	Pair Corr
0.62	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.44	DXCM	DexCom Inc	Pair Corr

The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.

The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Biomerica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:

How To Invest In Biomerica

Details

Is Biomerica Stock a good investment?

Details

What is Biomerica's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Biomerica Stock analysis

When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.

	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.

Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.37)

Revenue Per Share

0.323

Quarterly Revenue Growth

(0.09)

Return On Assets

(0.43)

Return On Equity

(0.92)

The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomerica Enterprise Value vs Working Capital Analysis

Enterprise Value vs Working Capital

Enterprise Value vs Working Capital Correlation Analysis

Correlation Coefficient

Enterprise Value

Working Capital

Biomerica fundamental ratios Correlations

Biomerica Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomerica fundamental ratios Accounts

Pair Trading with Biomerica

Moving together with Biomerica Stock

Moving against Biomerica Stock

Complementary Tools for Biomerica Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Other Stockholder Equity

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Common Stock	- 0.94	Retained Earnings
Property Plant And Equipment Gross	- 0.93	Retained Earnings